Holding(s) in Company
18 April 2008 - 11:12PM
UK Regulatory
RNS Number:6678S
EiRx Therapeutics PLC
18 April 2008
Financial Services Authority
TR-1 i: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying Eirx Therapeutics Plc
issuer of existing shares to which
voting rights are attached ii:
2. Reason for notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation iii: Barclays PLC
4. Full name of shareholder(s) (if different from 3):
Barclays Stockbrokers Ltd
5. Date of transaction and date on which the threshold is
crossed or reached v: 17-Apr-08
6. Date on which issuer notified: 18-Apr-08
7. Threshold(s) that is/are crossed or reached: 7% to 6%
8. Notified details:
A: Voting rights attached to shares
Class/type Situation Resulting situation after the triggering transaction vii
of shares previous to the
Triggering
if possible transaction vi
using the ISIN
CODE
Number Number Number Number of Voting Rights % of voting rights
Of Of Of
Shares Voting Shares
Rights viii Direct x Indirect xi Direct Indirect
GB00B0XQBS97 517,067,792 517,067,792 468,567,792 0 468,567,792 0.00 6.72
B: Financial Instruments
Resulting situation after the triggering transaction xii
Type of financial Expiration Exercise/Conversion No. of voting Percentage of voting
instrument Period/Date xiv rights
date xiii rights that may be
acquired if the
instrument exercised/
converted
N/A N/A N/A N/A N/A
Total (A+B)
Number of voting rights Percentage of voting rights
468,567,792 6.72
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively
held, if applicable xv :
Barclays Stockbrokers Ltd
Proxy Voting:
10. Name of proxy holder: N/A
11. Number of voting rights proxy holder will cease N/A
to hold:
12. Date on which proxy holder will cease to hold N/A
voting rights:
13. Additional information: N/A
14. Contact name: Geoff Smith
15. Contact telephone number 020 7116 2913
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWRORWNRSAAR
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Eirx Therap. (London Stock Exchange): 0 recent articles
More Eirx Therapeutic Plc News Articles